Teva Investigational Site 10598 — Ashland, Oregon

Teva Investigational Site 10598 is a clinical research site located in Ashland, Oregon, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 10598 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ashland

Browse all research sites in Oregon · View every site in Ashland

• Oregon Health & Science University, School of Nursing
• Integrated Medical Research PC
• GSK Investigational Site
• Altana/Nycomed
• Altana Pharma/Nycomed
• Retina & Vitreous Center SO
• Alkeus Site
• Forest Investigative site 062
• 205.452.01266 Boehringer Ingelheim Investigational Site
• Teva Investigational Site 11108
• Retina & Vitreous Center of So. Oregon
• Influence Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 10598?

Teva Investigational Site 10598 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 10598 conducted?

Teva Investigational Site 10598 has 1 clinical trials on record. Their work covers Asthma.

Is Teva Investigational Site 10598 accredited by Crixeo Clinical Trials?

Teva Investigational Site 10598 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 10598?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.